image
Rocket Pharmaceuticals, Inc. RCKT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.7
-4.59 %
$ 291 M
Market Cap
-1.03
P/E
Price Target Average
878.40%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
32.88%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Rocket Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for RCKT of $26.4 , with forecasts ranging from a low of $2 to a high of $45 .
RCKT Lowest Price Target Wall Street Target
2 USD -25.93%
RCKT Average Price Target Wall Street Target
26.4 USD 878.40%
RCKT Highest Price Target Wall Street Target
45 USD 1566.67%
Price
Max Price Target
Min Price Target
Average Price Target
454540403535303025252020151510105500Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart RCKT

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RCKT

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RCKT

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)2022202220232023202420242025202520262026202720272028202820292029